SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-12-043949
Filing Date
2012-06-15
Accepted
2012-06-15 17:26:51
Documents
1
Group Members
ORBIMED CAPITAL GP III LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a12-14807_1sc13da.htm SC 13D/A 148051
  Complete submission text file 0001104659-12-043949.txt   149801
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Subject) CIK: 0001396814 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86096 | Film No.: 12910906
SIC: 2834 Pharmaceutical Preparations